• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Mahmoud, M. (2021). COMPARING PLATELET TO LYMPHOCYTE RATIO & NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN IN PREDICTING OUTCOMES IN CRITICAL PATIENTS WITH ACUTE KIDNEY INJURY. ALEXMED ePosters, 3(4), 35-36. doi: 10.21608/alexpo.2021.87846.1232
Mahmoud Medhat Mahmoud. "COMPARING PLATELET TO LYMPHOCYTE RATIO & NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN IN PREDICTING OUTCOMES IN CRITICAL PATIENTS WITH ACUTE KIDNEY INJURY". ALEXMED ePosters, 3, 4, 2021, 35-36. doi: 10.21608/alexpo.2021.87846.1232
Mahmoud, M. (2021). 'COMPARING PLATELET TO LYMPHOCYTE RATIO & NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN IN PREDICTING OUTCOMES IN CRITICAL PATIENTS WITH ACUTE KIDNEY INJURY', ALEXMED ePosters, 3(4), pp. 35-36. doi: 10.21608/alexpo.2021.87846.1232
Mahmoud, M. COMPARING PLATELET TO LYMPHOCYTE RATIO & NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN IN PREDICTING OUTCOMES IN CRITICAL PATIENTS WITH ACUTE KIDNEY INJURY. ALEXMED ePosters, 2021; 3(4): 35-36. doi: 10.21608/alexpo.2021.87846.1232

COMPARING PLATELET TO LYMPHOCYTE RATIO & NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN IN PREDICTING OUTCOMES IN CRITICAL PATIENTS WITH ACUTE KIDNEY INJURY

Article 204, Volume 3, Issue 4, December 2021, Page 35-36  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.87846.1232
View on SCiNiTO View on SCiNiTO
Author
Mahmoud Medhat Mahmoud email
Department of critical care. Alexandria university
Abstract
Acute kidney injury (AKI) is clinically defined as acute decrease in glomerular filtration rate (GFR) reflected by rising serum creatinine (SCr) and/or drop in urine output over a given period of time. The incidence rates of AKI are affected by both the definition of AKI used and the studied population.
Neutrophil gelatinase-associated lipocalin (NGAL) also referred to as lipocalin 2, It belongs to the Lipocalin glycoproteins family.
Platelets and lymphocytes (PLR) plays critical roles in the inflammatory process. It is novel inflammatory factor that has received research attention recently, as it may act as an indicator of inflammation. (NGAL) has been recently highlighted as a biomarker for acute kidney diseases.
AIM OF THE WORK
The aim of the work was to compare accuracy of platelet-to-lymphocyte ratio to serum gelatinase associated lipocalin as a predictor of the morbidity and mortality in critically ill patients with acute kidney injury.
SUBJECTS AND METHODS
This study was carried on sixty adult patients of both sex who were admitted to the Critical Care Medicine Department in Alexandria Main University Hospital with diagnosis of AKI.
Serum NGAL was measured for all patients on admission and PLR was calculated for all patients.
Patients were followed up for 28 days and the following were recorded; length of ICU stay, need for vasopressors, need for mechanical ventilation, need for renal replacement therapy and 28-day mortality.
Patients were classified into two groups according to mortality; Group I (survival) & Group II (non-survival).
Keywords
AKI; PLR; NGAL
Supplementary Files
download 0035-1232 Presentation9.pdf
Statistics
Article View: 192
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.